2,alpha-DMT
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
1-(2-methyl-1H-indol-3-yl)propan-2-amine | |
Clinical data | |
Legal status | ? |
Identifiers | |
CAS number | 4966-28-3 |
ATC code | ? |
ChemSpider | 23511903 |
Chemical data | |
Formula | C12H16N2 |
| |
| |
(what is this?) (verify) | |
2,alpha-DMT, or 2,α-dimethyltryptamine, is a tryptamine and a lesser-known psychedelic drug. It is the 2,a-dimethyl analog of DMT. 2,α-DMT was first synthesized by Alexander Shulgin. In his book TiHKAL (Tryptamines I Have Known and Loved), Shulgin lists the dosage as 300-500 mg, and the duration as 7-10 hours.[1] 2,α-DMT causes mydriasis and paresthesia. It also produces a calm, drunk-like feeling. Very little data exists about the pharmacological properties, metabolism, and toxicity of 2,α-DMT.
References
- ↑ Shulgin, Alexander; Ann Shulgin (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press, 422. ISBN 0-9630096-9-9. OCLC 38503252.
External links
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.